INS and type 2 diabetes mellitus: The first definitive study to show that improving glycemic control in type 2 diabetes lowered the risk of complications, tested the effects of intensified treatment with the sulfonylurea insulin secretagogues as primary therapy to which insulin could be added, vs. standard care with diet and addition of sulfonylureas to treatment only to prevent severe hyperglycemia.